{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:28:21Z","timestamp":1790166501321,"version":"4.1.0"},"reference-count":35,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,10,13]]},"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Prenatal exposure to antiepileptic drugs (AEDs) has been associated with adverse outcomes in the offspring such as congenital malformations and neuropsychiatric disorders. The objective of this study was to investigate whether prenatal exposure to AEDs is also associated with more frequent use of primary healthcare during childhood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Population-based cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Nationwide national registers in Denmark.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>All live-born singletons in Denmark during 1997\u20132012 identified in the Danish National Patient Register and followed until 31 December 2013 (n=963\u2005010). Information on prenatal exposure to AEDs for maternal indication of epilepsy and other neurological conditions was obtained from the Danish Register of Medicinal Product Statistics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>The primary outcome measure was the number and type of contacts with the general practitioner (GP), excluding routine well-child visits and vaccinations. The secondary outcome measure was specific services provided at the GP contact. The association between prenatal exposure to AEDs and contacts with the GP was estimated by using negative binomial regression adjusting for sex and date of birth of the child, maternal age, cohabitation status, income, education, substance abuse, depression, severe psychiatric disorders and use of antipsychotics, antidepressants and insulin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Children exposed prenatally to AEDs (n=4478) had 3% (95% CI 0 to 5%) more GP contacts during the study period than unexposed children. This was primarily accounted for by the number of phone contacts. Within each year of follow-up, exposed children tended to have more contacts than unexposed children, but the differences were small. We found no difference between exposed and unexposed children with regard to specific services provided at the GP contact. For the individual AEDs, we found that exposure to valproate or oxcarbazepine was associated with more GP contacts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We found only minor differences between prenatally AED-exposed and unexposed children in the number of GP contacts.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-012836","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T20:50:21Z","timestamp":1483995021000},"page":"e012836","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Prenatal exposure to antiepileptic drugs and use of primary healthcare during childhood: a population-based cohort study in Denmark"],"prefix":"10.1136","volume":"7","author":[{"given":"Anne Mette","family":"W\u00fcrtz","sequence":"first","affiliation":[{"name":"Research Unit for General Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-0975","authenticated-orcid":false,"given":"Dorte","family":"Rytter","sequence":"additional","affiliation":[{"name":"Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus H\u00f8strup","family":"Vestergaard","sequence":"additional","affiliation":[{"name":"Research Unit for General Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9385-6435","authenticated-orcid":false,"given":"Jakob","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogens","family":"Vestergaard","sequence":"additional","affiliation":[{"name":"Research Unit for General Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Section for General Medical Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil Hammer","family":"Bech","sequence":"additional","affiliation":[{"name":"Research Unit for General Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"key":"2025101811304539000_7.1.e012836.1","doi-asserted-by":"publisher","DOI":"10.4065\/71.6.576"},{"key":"2025101811304539000_7.1.e012836.2","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.12004"},{"key":"2025101811304539000_7.1.e012836.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2270"},{"key":"2025101811304539000_7.1.e012836.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02129.x"},{"key":"2025101811304539000_7.1.e012836.5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40264-015-0269-9","article-title":"Neurodevelopmental effects of fetal antiepileptic drug exposure","volume":"38","author":"Velez-Ruiz","year":"2015","journal-title":"Drug Saf"},{"key":"2025101811304539000_7.1.e012836.6","doi-asserted-by":"crossref","first-page":"e007425","DOI":"10.1136\/bmjopen-2014-007425","article-title":"Apgar-score in children prenatally exposed to antiepileptic drugs: a population-based cohort study","volume":"5","author":"Christensen","year":"2015","journal-title":"BMJ Open"},{"key":"2025101811304539000_7.1.e012836.7","doi-asserted-by":"crossref","first-page":"e58213","DOI":"10.1371\/journal.pone.0058213","article-title":"Developmental enamel defects in children prenatally exposed to anti-epileptic drugs","volume":"8","author":"Jacobsen","year":"2013","journal-title":"PLoS ONE"},{"key":"2025101811304539000_7.1.e012836.8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.yebeh.2013.08.033","article-title":"Preschool behavioral problems in children prenatally exposed to antiepileptic drugs\u2014a follow-up study","volume":"29","author":"Kjaer","year":"2013","journal-title":"Epilepsy Behav"},{"key":"2025101811304539000_7.1.e012836.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.10.031"},{"key":"2025101811304539000_7.1.e012836.10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.0000000000002119","article-title":"Developmental effects of antiepileptic drugs and the need for improved regulations","volume":"86","author":"Meador","year":"2016","journal-title":"Neurology"},{"key":"2025101811304539000_7.1.e012836.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70107-7"},{"key":"2025101811304539000_7.1.e012836.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2010.07.019"},{"key":"2025101811304539000_7.1.e012836.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8510(01)00201-9"},{"key":"2025101811304539000_7.1.e012836.14","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2012.02.110216"},{"key":"2025101811304539000_7.1.e012836.15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2025101811304539000_7.1.e012836.16","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810387965"},{"key":"2025101811304539000_7.1.e012836.17","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810394717"},{"key":"2025101811304539000_7.1.e012836.18","unstructured":"WHO. WHO Collaborating Centre for Drug Statistics Methodology (WHOCC). Oslo, Norway. Anatomical Therapeutic Chemical (ATC) classification system. 2011:2016. http:\/\/www.whocc.no\/atc\/structure_and_principles\/ (accessed online Nov 2016).http:\/\/www.whocc.no\/atc\/structure_and_principles\/"},{"key":"2025101811304539000_7.1.e012836.19","unstructured":"WHO. WHO Collaborating Centre for Drug Statistics Methodology (WHOCC). Oslo, Norway. Defined daily dose; ATC\/DDD index, 2015. http:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"2025101811304539000_7.1.e012836.20","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810394718"},{"key":"2025101811304539000_7.1.e012836.21","unstructured":"Statistics Denmark, Copenhagen, Denmark. 2016. http:\/\/www.dst.dk\/en (accessed online November 2016)."},{"key":"2025101811304539000_7.1.e012836.22","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810395825"},{"key":"2025101811304539000_7.1.e012836.23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2007.08.004","article-title":"The association between maternal depression and frequent non-routine visits to the infant's doctor\u2014a cohort study","volume":"107","author":"Chee","year":"2008","journal-title":"J Affect Disord"},{"key":"2025101811304539000_7.1.e012836.24","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200109000-00006"},{"key":"2025101811304539000_7.1.e012836.25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/CLEP.S4782","article-title":"Association of Apgar scores with death and neurologic disability","volume":"1","author":"Ehrenstein","year":"2009","journal-title":"Clin Epidemiol"},{"key":"2025101811304539000_7.1.e012836.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.10.041"},{"key":"2025101811304539000_7.1.e012836.27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0945"},{"key":"2025101811304539000_7.1.e012836.28","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000208478.47401.b6"},{"key":"2025101811304539000_7.1.e012836.29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-6-23"},{"key":"2025101811304539000_7.1.e012836.30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bmjopen-2012-001095","article-title":"The 5-minute Apgar score as a predictor of childhood cancer: a population-based cohort study in five million children","volume":"2","author":"Li","year":"2012","journal-title":"BMJ Open"},{"key":"2025101811304539000_7.1.e012836.31","unstructured":"Glymour MM , Greenland S . Chapter 12: causal diagrams. In: Rothman KJ , Greenland S , Lash TL, eds . Modern epidemiology. Philadelphia, USA: Lippincott Williams & Wilkins, 2008:183\u2013209."},{"key":"2025101811304539000_7.1.e012836.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005657"},{"key":"2025101811304539000_7.1.e012836.33","first-page":"CD010236","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","volume":"10","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025101811304539000_7.1.e012836.34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.reprotox.2016.06.007","article-title":"The treatment of epilepsy in pregnancy: the neurodevelopmental risks associated with exposure to antiepileptic drugs","volume":"64","author":"Bromley","year":"2016","journal-title":"Reprod Toxicol"},{"key":"2025101811304539000_7.1.e012836.35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/11317640-000000000-00000","article-title":"Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies","volume":"33","author":"Banach","year":"2010","journal-title":"Drug Saf"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-012836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:30:55Z","timestamp":1760812255000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-012836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,5]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1136\/bmjopen-2016-012836"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-012836","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}